-
Mashup Score: 1
An international consensus statement calling for urgent action to address chronic kidney disease has been published in Nature Reviews Nephrology.The global public health agenda from the American Society of Nephrology, European Renal Association and International Society of Nephrology highlighted critical policy, advocacy efforts and implementation needs within the kidney care community.
Source: www.healio.comCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 1Adolescent Body Mass Index and Early Chronic Kidney Disease - 4 month(s) ago
This cohort study evaluates the association between body mass index in late adolescence and early chronic kidney disease during young adulthood.
Source: jamanetwork.comCategories: General Medicine News, General HCPsTweet-
High adolescent BMI increases the risk of early #chronicKidneyDisease, large cohort study finds @JAMAPeds https://t.co/ZJkzREaRaz https://t.co/sZRmUyOR5W
-
-
Mashup Score: 4Methotrexate Carries Higher Risk for Older CKD Patients - 5 month(s) ago
Adverse event data showed an increased risk of myelosuppression, sepsis, pneumotoxic effects, or hepatotoxic effects.
Source: www.medscape.comCategories: General Medicine News, General HCPsTweet-
Low-dose methotrexate carries higher risk for older patients with CKD #ChronicKidneyDisease https://t.co/X8dVUh4c4j https://t.co/2XFUODMZVE
-
-
Mashup Score: 1
On October 17, 2023, Ardelyx Inc announced the FDA approval of tenapanor (Xphozah) for reducing serum phosphorus in adults with chronic kidney disease on dialysis as add-on therapy.
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet-
BREAKING: @ardelyx announced the FDA approval of tenapanor for reducing serum phosphorous in adults with CKD on dialysis. Learn more: https://t.co/exdrAQmNuZ #Nephrology #ChronicKidneyDisease https://t.co/2lISp71Sn9
-
-
Mashup Score: 0
On October 10, 2023, Novo Nordisk announced they would be stopping the FLOW trial, which examined the effects of semaglutide 1.0 mg on kidney outcomes in type 2 diabetes, due to early efficacy based on an interim analysis of the trial.
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet-
Yesterday, Novo Nordisk announced plans to halt the FLOW trial after early efficacy awas observed in an interim analysis by the independent Data Monitoring Committee. https://t.co/gRLlGLNOlP #ChronicKidneyDisease
-
-
Mashup Score: 1Empagliflozin (Jardiance) Receives CKD Approval from US FDA - 7 month(s) ago
HCPLive is a comprehensive clinical news and information portal that provides physicians with up-to-date specialty and disease-specific resources designed to help them provide better care to patients. At HCPLive, you will find breaking news, video interviews with physician experts, in-depth conference coverage, finance and practice management updates, insight and analysis from physician contributors, and more.
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet-
Earlier today, Boehringer Ingelheim and Eli Lilly and Company announced the FDA approval of empagliflozin for CKD. Learn more: https://t.co/IzAjNxHX40 #ChronicKidneyDisease
-
-
Mashup Score: 0
Researchers investigated the relationship between vegetable and fruit intake frequency and all-cause mortality in patients with CKD.
Source: www.emjreviews.comCategories: Latest Headlines, NephrologyTweet-
A recent study has investigated the relationship between vegetable and fruit intake frequency and all-cause mortality in patients with chronic kidney disease. Learn more with @EMJReviews 👉 https://t.co/14Y8xdxbqV #ChronicKidneyDisease #CKD #FruitandVeg
-
-
Mashup Score: 0Relationships of Chronic Kidney Disease and Thyroid Dysfunction in Patients with Stage 4 and 5 Chronic Kidney Disease: A Cross-Sectional Study - 11 month(s) ago
A spectrum of various pathophysiological processes associated with a progressive worsening in estimated glomerular filtration rate (eGFR)…
Source: European Medical JournalCategories: Latest Headlines, NephrologyTweet-
This fascinating article explores the challenges of patients with Stage 4 and Stage 5 chronic kidney disease who are affected by thyroid problems. Read now 👉 https://t.co/RU4dPPGOA0 #ChronicKidneyDisease #ThyroidDysfunction #KidneyHealth
-
-
Mashup Score: 3JCI - Transcription factor HNF4α2 promotes osteogenesis and prevents bone abnormalities in mice with renal osteodystrophy - 11 month(s) ago
Research ArticleBone BiologyMetabolism Open Access | 10.1172/JCI159928 Guillaume Courbon,1 Bridget Hunt-Tobey,1 Connor Francis,1 Jadeah Spindler,1 Xueyan Wang,1 Luciene M. dos Reis,2 Carolina S.W. Martins,2 Isidro B. Salusky,3 Hartmut Malluche,4 Thomas L. Nickolas,5 Rosa M.A. Moyses,2 Aline Martin,1…
Source: www.jci.orgCategories: General Medicine News, Latest HeadlinesTweet-
Transcription factor prevents #bone frailty in #chronickidneydisease @northwesternu @jclinicalinvest https://t.co/t4UbNcwMuO https://t.co/bnRsKYeG4h
-
-
Mashup Score: 4Potential Therapeutic Target for Chronic Kidney Disease Uncovered - 11 month(s) ago
A team of researchers from the University of Edinburgh has uncovered in mice novel insights into a protein that causes damage in kidneys and hearts that may lead to new treatment options for chronic kidney disease.
Categories: Future of Medicine, Latest HeadlinesTweet-
A team of researchers from @EdinburghUni has uncovered in mice novel insights into a protein that causes damage in kidneys and hearts that may lead to new treatment options for #chronickidneydisease. Learn more: https://t.co/tN3IOi4H15 https://t.co/C7IQgOTEVC
-
🔊 An international consensus statement among @ASNKidney, @ERAkidney and @ISNkidneycare calls for urgent action to address #chronickidneydisease. ✅ At the top of the agenda is improved access to affordable kidney care services. https://t.co/USm2yMmIle